This white paper explores how integrated preclinical platforms—including orthotopic PDX models, humanized systems, and AI-driven predictive analytics—can bridge the gap between preclinical research and clinical success in glioblastoma. Learn how...

Explore potential applications of CertisAI across therapeutic modalities – from small molecules to antibody-drug conjugates (ADCs), monoclonal antibodies (mAbs), bispecific antibodies (BsAbs), and peptides – and demonstrate how this powerful...

For cancer researchers advancing ADCs, cell therapies, and other targeted therapies, translational relevance of preclinical models matters more than ever. By downloading this white paper, you’ll get a comprehensive guide to selecting the most...